ArticleOncoTargets and therapy2017

Durable complete remission of poor performance status metastatic lung adenocarcinoma patient treated with second-line erlotinib: a case report.

Dragana Jovanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.